These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32237002)

  • 21. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
    Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
    Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
    Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
    Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the knowledge, behavior and health beliefs of individuals over 50 regarding colorectal cancer screening.
    Tastan S; Andsoy II; Iyigun E
    Asian Pac J Cancer Prev; 2013; 14(9):5157-63. PubMed ID: 24175793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
    Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
    Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
    J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.
    Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
    Wieten E; de Klerk CM; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1392-1399.e5. PubMed ID: 30055170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer screening: Systematic review of screen-related morbidity and mortality.
    Vermeer NC; Snijders HS; Holman FA; Liefers GJ; Bastiaannet E; van de Velde CJ; Peeters KC
    Cancer Treat Rev; 2017 Mar; 54():87-98. PubMed ID: 28236723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing awareness of colorectal cancer symptoms and screening in a peripheral colorectal surgical unit: a survey based study.
    McVeigh TP; Lowery AJ; Waldron RM; Mahmood A; Barry K
    BMC Surg; 2013 Jun; 13():20. PubMed ID: 23799887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Psychological Impact of a Colorectal Cancer Diagnosis Following a Negative Fecal Occult Blood Test Result.
    Miles A; McClements PL; Steele RJ; Redeker C; Sevdalis N; Wardle J
    Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1032-8. PubMed ID: 25924826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
    Brenner H; Hoffmeister M; Birkner B; Stock C
    Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colonoscopic screening for colorectal cancer improves quality of life measures: a population-based screening study.
    Taupin D; Chambers SL; Corbett M; Shadbolt B
    Health Qual Life Outcomes; 2006 Oct; 4():82. PubMed ID: 17044941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 37. A stitch in time saves nine: Perceptions about colorectal cancer screening after a non-cancer colonoscopy result. Qualitative study.
    Kirkegaard P; Edwards A; Andersen B
    Patient Educ Couns; 2019 Jul; 102(7):1373-1379. PubMed ID: 30853142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.
    Borges LV; Mattar R; Silva JMKD; Silva ALWD; Carrilho FJ; Hashimoto CL
    Arq Gastroenterol; 2018; 55(2):128-132. PubMed ID: 30043860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
    Hundt S; Haug U; Brenner H
    Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.